Associate Scientist - Genetic Medicines, In Vivo
Regeneron Pharmaceuticals
About this role
An Associate Scientist in Regeneron's Genetic Medicines group will support pre-clinical gene therapy programs by working on in vivo studies in mice and contributing to translational research efforts. The role offers exposure to multiple technologies across discovery through clinical development and opportunities for career growth in gene therapy.
Skills
Qualifications
About Regeneron Pharmaceuticals
regeneron.comDiscover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Recent company news
MarketBeatQuadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
The Globe and MailIn 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Simply Wall StWill Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Seeking AlphaRegeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
MarketBeatCapital Research Global Investors Raises Stake in Regeneron Pharmaceuticals, Inc. $REGN
7 hours ago
About Regeneron Pharmaceuticals
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Salary
$70k – $110k
per year
More jobs at Regeneron Pharmaceuticals
Similar Jobs
In Vivo Specialist II
AskBio
ADME Project Leadership for Genetic Medicines
Eli Lilly and Company
In vivo Pharmacologist
Artech
Scientist II, In Vivo, Enzymatic and Metabolic Therapeutic Area
biomarin
ADME Project Leadership for Genetic Medicines
Eli Lilly and Company
Senior Scientist, In vivo Cardiovascular
AstraZeneca